DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 173 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,633,583 | -30.1% | 176,131 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $5,197,626 | +28.1% | 176,131 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $4,058,058 | -24.6% | 176,131 | -9.0% | 0.00% | -20.0% |
Q4 2022 | $5,382,931 | -12.2% | 193,561 | -3.1% | 0.01% | -16.7% |
Q3 2022 | $6,134,000 | +3.1% | 199,855 | -1.1% | 0.01% | 0.0% |
Q2 2022 | $5,950,000 | -8.5% | 202,177 | 0.0% | 0.01% | +20.0% |
Q1 2022 | $6,504,000 | -27.9% | 202,177 | 0.0% | 0.01% | -16.7% |
Q4 2021 | $9,017,000 | -11.2% | 202,177 | +0.4% | 0.01% | -25.0% |
Q3 2021 | $10,159,000 | -34.8% | 201,374 | +1.4% | 0.01% | -33.3% |
Q2 2021 | $15,583,000 | +67.1% | 198,661 | +21.6% | 0.01% | +71.4% |
Q1 2021 | $9,326,000 | -27.6% | 163,332 | +6.1% | 0.01% | -30.0% |
Q4 2020 | $12,890,000 | +152.0% | 153,898 | +7.8% | 0.01% | +100.0% |
Q3 2020 | $5,116,000 | +52.0% | 142,772 | +2.6% | 0.01% | +66.7% |
Q2 2020 | $3,365,000 | +76.8% | 139,172 | +28.1% | 0.00% | +50.0% |
Q1 2020 | $1,903,000 | +0.6% | 108,673 | +0.1% | 0.00% | 0.0% |
Q4 2019 | $1,891,000 | +39.2% | 108,573 | +22.4% | 0.00% | +100.0% |
Q3 2019 | $1,358,000 | +325.7% | 88,673 | +476.5% | 0.00% | – |
Q2 2019 | $319,000 | +43.7% | 15,382 | +60.5% | 0.00% | – |
Q1 2019 | $222,000 | – | 9,582 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |